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135 for internal exposure. Theses ions seem to be taken up 
by the cells. However more knowledge about the bio-kinetics 
of these auger emitters is needed to estimate the dose rates 
and the dose distribution in the cell. As the cells take up the 
Auger emitter, the dose rate by the internal Auger decays are 
continuously changing as a function of cellular accumulation 
and half-life of the isotope. 
Uptake curves are therefore produced by incubating HeLa 
cells with Auger-electron emitters for various amounts of 
time and with different levels of radioactivity to calculate 
the changing dose rate and accumulated dose.  These 
conditions will be mimicked as closely as possible with 
external γ-rays, by moving the cells closer to the source (Cs-
137). DNA damage will be assessed by flow cytometry 
measurements (MUSE) of phosphorylated histone H2AX (γ-
H2AX) and/or the clonogenic cell survival assay.  
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Purpose: The importance of MRI steadily increases in 
radiation oncology not only as multimodality imaging device 
but also as an implemented online imaging technology. 
Imaging using MRI shows advantages compared to CT or CBCT 
offering superior soft tissue contrast without additional dose. 
Also in particle beam therapy integrated MR guided 
treatment units have great potential. A complete 
understanding of the particle beam characteristics in the 
presence of magnetic fields is required. So far, studies in this 
area are limited. 
Material and Methods: Protons (60-250MeV) and carbon ions 
(120-400MeV/u) in the clinically required energy range 
impinging on a phantom of 35x35x50cm³ size were simulated 
using the MC framework GATE 7. Homogeneous magnetic 
fields of 0.35T, 1T and 3T perpendicular to the initial beam 
axis were applied. The beam deflection, shape, and the 
energy spectrum at the Bragg peak area was analyzed. A 
numerical algorithm was developed for deflection curve 
generation solving the relativistic equations of motion taking 
into account the Lorentz force and particle energy loss. 
Additionally, dose variations on material boundaries induced 
by magnetic fields were investigated for 250MeV protons. 
Results: Transverse deflections up to 99mm were observed 
for 250MeV protons at 3T. Deflections for lower field 
strengths (e.g. future hybrid open-MRI proton delivery 
systems) yielded 12mm for 0.35T and 34mm for 1T. A change 
in the dose distribution at the Bragg-peak region was 
observed for protons. Energy spectrum analysis showed an 
asymmetric lateral energy distribution. The different particle 
ranges resulted in a tilted dose distribution, see Fig.1.The 
numerical algorithm successfully modeled the deflection 
curve, with a maximum deviation of 1.8% and calculation 
times of less than 5ms. For a 250MeV proton beam passing in 
a 3T field through multiple slabs (water-air-water), only a 4% 
local dose increase at the first boundary was observed in 
single voxels due to the electron return effect, more than a 
factor 10 lower compared to a photon beam [1]. 
 
 
 
Fig1: Deformed 2D dose distribution at the Bragg peak area 
for a 250MeV proton beam in a 3T field 
 
Conclusion: Beam deflections in magnetic fields could be 
described by a numerical algorithm. The observed change in 
dose distribution in the Bragg-peak region has to be taken 
into account in future dose calculations. However, local dose 
changes due to boundary effects seem to be negligible for 
clinical applications. Current work in progress deals with the 
inclusion of magnetic field effects in a dose calculation 
algorithm for particles. 
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The mechanism of tumor cure by ionizing radiation is 
regarded tumor cell autonomous, effected by misrepair of 
radiation-induced DNA double strand breaks (DSBs), to a large 
extent via the function of error prone non-homologous end 
joining (NHEJ). This model prevails at the low dose range, 
with cure depending on tumor phenotypic propensity for 
NHEJ misrepair, and requires repeated exposures for tumor 
ablation.  Here we report high (>10Gy) single dose 
radiotherapy (SDRT) employs an alternative dual target 
model, inducing in addition to DSBs also an early wave of 
acid sphingomyelinase (ASMase)-mediated microcirculatory 
ischemia/reperfusion (I/R) injury. Reactive oxygen species 
(ROS) induced therein in parenchymal tumor cells disrupt 
activation of homology-directed repair (HDR), leading to 
catastrophic reprograming of DSB repair. We show Ku- and 
53BP1-mediated NHEJ are not affected, although 
MDC1/53BP1 resolution is delayed, while engagement of the 
HDR mediator cluster in DSB repair is aborted, promoting a 
divergent DSB repair pathway, generation of massive 
chromosomal alteration and reproductive tumor clonogen 
demise. Scavenging of ROS with the SOD-mimetic tempol 
reversed the loss-of-function HDR and tumor cell lethality, 
aborting tumor cure by SDRT. We define I/R-mediated loss-
of-function HDR as the detrimental SDRT damage response, 
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conferring synthetic tumor clonogen lethality, with far 
reaching clinical implications.  
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Purpose: The main focus of the present study is to investigate 
dose enhancement effects in presence of gold nanoparticles 
(AuNPs) in proton delivery site of the ocular melanoma by the 
use of fixed pencil beam method associated with the Harvard 
ocular nozzle in a series of Monte Carlo simulations. 
Moreover, this paper also aims to present a comparison of 
the obtained results between the actual eye model, 
consisting of all sections of the eye and realistic compositions 
in the presence of AuNPs, and in the exact same organ, albeit 
in privation of the mentioned material.  
Materials and Methods: Previous Monte-Carlo simulations 
have strained to acquire the same results obtained through 
latest experiments that have considered dose enhancement 
effects of proton treatments with existence of AuNPs, but to 
no avail; thus, multiple simulation codes such as MCNP, 
GEANT4, and FLUKA have been taken into account to insure 
the least possible deviation from in vivo findings. Rigorous 
libraries and models have been used, and all physical 
processes involved have been accounted for.Furthermore, for 
the sake of accuracy, the production of the most probable 
secondary particles due to interactions with matter has also 
been examined.Contribution to dose enhancement effects 
are due to stopping losses, coulomb interactions, and elastic 
and non-elastic collisions of proton itself, as well as from 
secondary particles that are produced in mentioned 
processes.  
Results and Conclusions: The attempt of such paper is to shed 
light on the endless possibilities of escalating the efficiency 
of medical endeavors through interdisciplinary methods 
which combine various aspects of science and technology to 
attain desired results. 
 
Keywords: Proton-therapy, AuNPs, MC Simulations 
 
91 
Characterization of the immune component in the lung 
of KP mouse with pulmonary adenocarcinoma: from 
infiltrated immune cells to tertiary lymphoid structures. 
B. Gael1*, J. Faget2*, J. Bourhis1, E. Meylan2° and M-C. 
Vozenin1°. 
1 Unil-CHUV 
2 EPFL ISREC  
* and ° Contributed equally 
 
Introduction: In this preliminary work, we developped a 
method to phenotype and analyse the tumour infiltrating 
immune cells (TIICs) and identified tertiary lymphoid 
structures (TLS) as potential immune reservoir in 
lslKrasG12D P53fl/fl mice model. As radiotherapy as been 
described to act on the recruitment, removal, 
reorganisation, repolarisation and activation of immune cells 
(1), our final goal will be to define optimal radiotherapy 
scheme to stimulate immune response. 
Material & method: lslKrasG12D P53fl/fl mice were used 
and tumours genenerated by intratracheal admnistration 
of LentiCre to generate numerous widespread lung 
autochonous tumours. Those were macrodissected, 
weighed and measured to analyse TIICs with a 16 colours 
facs pannel. TLS were identified, anayzed in serial lung 
sections and the TLS/ tumors ratio was assessed. Both 
TIICs and TLS were studied with IHC and/or IF. (B220, 
LY6G, CD3, Lyve1, Prox1, CD163, CD68, KI67, CXCR4, 
Ecadhérin, CD205). 
Results: Size of tumors positively correlated with high 
amount of CD80- macrophages/monocytes, MDSCs and 
Tregs, but was inversely proportionnal with the amount of 
NK1.1+, B220+, Ly6g+ cells and CD8/FoxP3 ratio. 
Histological analysis showed that immune cells were not 
strongly infiltrating tumors but located in aggregates 
defined as TLS in the vincinity of tumours and were mostly 
composed of B220+ cells and CD163+ macrophages.. TLS 
were approximately 50 uM sized and the tumour/TLS ratio 
was heteroeneous on 4um section, ranging from 0,5 to 
6,6. However, TLS were not observed in tumour-free 
control KP mouse. 
Conclusion: TLS are a known good prognosis factor in 
human lung cancer (2) and consistently with a recent 
publication (3) we report TLS infiltrates in tumour bearing 
KP mouse. Our hypothesis is that TLS may promote anti-
tumour immunity upon radiotherapy and is currently 
being tested using conventionnal and flash radiotherapy. 
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Purpose: The Center for Proton Therapy (CPT) of the Paul 
Scherrer Institute has a long history of technical innovation 
and development in the field of proton therapy and related 
quality assurance (QA) [1]. The unique integration of QA 
equipment for the second proton pencil beam scanning (PBS) 
gantry built at the CPT [2], Gantry2, allows extensive 
diagnostic of the treatment unit for performance 
improvement. Here we present our latest developments in 
detection systems and their performance for daily QA for 
PBS. 
Method: The daily QA equipment developed for Gantry2 
consists of a multi-layer ionization chamber (MLIC), a strip 
ionization chamber and two calibrated ionization chambers 
for dose measurement. The signals from the MLIC and strip 
monitor are first digitized by a multi-channel current-to-
frequency converter (TERA06 chip [3]) and then processed by 
detector specific electronics (DSE) modules designed at CPT. 
The DSE is fully integrated into the Gantry2 system, allowing 
recording of the data from external detectors for each 
delivered spot. The data recorded from November 2013 to 
October 2015 with Gantry2 consists of a set of comprehensive 
daily measurements for the proton energies, spots delivery 
parameters (size, shape, and parallelism) and dose 
measurements. 
Results: The results from the different detectors provide 
critical information about the performance of our treatment 
system. The range measurement shows a deviation of less 
than 0.5 mm water equivalent thickness (WET) over 115 
energies between 70 MeV and 230 MeV on a daily basis. This 
illustrates the good reliability of the beam delivery system. 
We compare two different MLIC systems with a water-based 
range measurement device as reference. The mean deviation 
of range between the devices is lower than 0.8 mm WET. The 
spot position during delivery provides crucial information 
about the stability of the gantry massive structure. 
Correlation between the gantry angle and the position of 
spots are clearly established. The results are all well within 
clinical tolerances. 
Conclusions: The in-house developed QA detectors and their 
integration into the Gantry2 system has provided unique 
possibilities for comprehensive and efficient daily QA. The 
results show the strong points of both the Gantry2 systems 
and the equipment developed in-house, such as the stability 
of the daily range measurements. The results are being used 
to draft the next, improved generation of QA devices at the 
CPT for new PBS techniques. 
 
